E-LIB Suche - Ergebnisse für: Lorente, Rufo

1

Psoriasis induced by antiTNF therapy in inflammatory bowel ..:

Sanz Segura, Patricia ; Gomollón, Fernando ; Casas, Diego...
Digestive and Liver Disease. , 2024

2

Clinical and treatment outcomes of a second subcutaneous or..:

Calafat, Margalida ; Torres, Paola ; Tosca-Cuquerella, Joan...
Therapeutic Advances in Gastroenterology. 17 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

3

Ustekinumab and vedolizumab for the prevention of postopera..:

Mañosa, Míriam ; Fernández-Clotet, Agnès ; Nos, Pilar...
Digestive and Liver Disease. 55 (2023) 1 - p. 46-52 , 2023

Link: https://doi.org/10.1016/..

4

Serum and Urine Metabolomic Profiling of Newly Diagnosed Tr..:

Aldars-García, Laila ; Gil-Redondo, Rubén ; Embade, Nieves...
Inflammatory Bowel Diseases. , 2023

Link: https://doi.org/10.1093/..

5

Psychosocial impact of the COVID-19 pandemic on patients wi..:

Hernández Camba, Alejandro ; Ramos, Laura ; Madrid Álvarez, María Blanca...
Gastroenterología y Hepatología (English Edition). 45 (2022) 9 - p. 668-676 , 2022

Link: https://doi.org/10.1016/..

6

Preferences and satisfaction of IBD patients after switchin..:

Taxonera, Carlos ; Martínez-Montiel, María Pilar ; Barreiro-de-Acosta, Manuel...
Therapeutic Advances in Gastroenterology. 14 (2021) - p. 175628482110561 , 2021

Link: https://doi.org/10.1177/..

7

Effectiveness and Safety of Ustekinumab in Ulcerative Colit..:

Chaparro, María ; Garre, Ana ; Iborra, Marisa...
Journal of Crohn's and Colitis. 15 (2021) 11 - p. 1846-1851 , 2021

Link: https://doi.org/10.1093/..

8

Effects of anti–TNF-alpha therapy on hemoglobin levels and ..:

Lucendo, Alfredo J ; Roncero, Óscar ; Serrano-Duenas, María Teresa...
Digestive and Liver Disease. 52 (2020) 4 - p. 400-407 , 2020

Link: https://doi.org/10.1016/..

9

Mo1860 REAL-WORLD LONG-TERM EFFECTIVENESS OF USTEKINUMAB IN..:

Iborra, Marisa ; Beltran, Belen ; Fernández-Clotet, Agnes...
Gastroenterology. 158 (2020) 6 - p. S-953 , 2020

Link: https://doi.org/10.1016/..

10

EpidemIBD: rationale and design of a large-scale epidemiolo..:

Chaparro, María ; Barreiro-de Acosta, Manuel ; Benítez, José Manuel...
Therapeutic Advances in Gastroenterology. 12 (2019) - p. 175628481984703 , 2019

Link: https://doi.org/10.1177/..

11

Effectiveness and Safety of the Sequential Use of a Second ..:

Casanova, María José ; Chaparro, María ; Mínguez, Miguel...
Inflammatory Bowel Diseases. , 2019

Link: https://doi.org/10.1093/..

12

Short and long‐term effectiveness and safety of vedolizumab..:

Chaparro, María ; Garre, Ana ; Ricart, Elena...
Alimentary Pharmacology & Therapeutics. 48 (2018) 8 - p. 839-851 , 2018

Link: https://doi.org/10.1111/..

13

Faecal Calprotectin Differentially Predicts Postoperative E..:

Verdejo, Cristina ; Lucendo, Alfredo ; Cruz, Daniel Hervías...
Gastroenterology. 152 (2017) 5 - p. S791-S792 , 2017

Link: https://doi.org/10.1016/..

14

Anemia at the time of diagnosis of inflammatory bowel disea..:

Lucendo, Alfredo J. ; Arias, Ángel ; Roncero, Óscar...
Digestive and Liver Disease. 49 (2017) 4 - p. 405-411 , 2017

Link: https://doi.org/10.1016/..

15

Incidence, Clinical Characteristics, and Management of Psor..:

Guerra, Iván ; Pérez-Jeldres, Tamara ; Iborra, Marisa...
Inflammatory Bowel Diseases. 22 (2016) 4 - p. 894-901 , 2016

Link: https://doi.org/10.1097/..